CJC-1295 (No DAC)

CJC-1295 without DAC is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to increase the secretion of endogenous growth hormone (GH). Unlike the DAC version, it does not bind to albumin, resulting in a shorter half-life and more rapid, transient GH release.

How It Works

CJC-1295 (no DAC) binds to GHRH receptors in the pituitary gland, triggering the release of growth hormone in a short-acting and more immediate pulse. This rise in GH can support fat metabolism, muscle repair, recovery, and overall tissue regeneration. Because of its shorter duration of action, it allows for more flexible and time-specific GH stimulation.

Dosage Overview

Typical dosing ranges from 100–200 mcg per day, administered via subcutaneous injection. It is commonly used 2–3 times per week or in split doses depending on protocol. It is usually taken on an empty stomach to enhance effectiveness. Cycles generally last 4–6 weeks, followed by an equal rest period. Reconstitution with bacteriostatic water and proper refrigeration are required for stability and potency.

Potential Benefits

CJC-1295 (no DAC) is associated with improved fat metabolism, enhanced recovery, better sleep quality, and support for lean muscle preservation. It may also contribute to increased collagen production, improved skin elasticity, and overall physical performance, making it popular in fitness and anti-aging applications.

Side Effects and Considerations

Possible side effects include mild headaches, flushing, fatigue, and minor injection site irritation. Temporary changes in water balance or blood sugar may also occur. While generally considered well-tolerated, monitoring is recommended due to its influence on growth hormone regulation.